Ninkovic, S., Harrison, S. J., Lee, J.-J., Murphy, N., Lee, J. H., Estell, J., Chen, V. M., Horvath, N., Kim, K., Eek, R., Augustson, B., Bang, S.-M., Huang, S.-Y., Rajagopal, R., Szabo, F., Engeler, D., Butcher, B. E., Mollee, P., Durie, B., Chng, W. J. and Quach, H. (2024) “Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study”, Haematologica. Pavia, Italy, 109(7), pp. 2229-2238. doi: 10.3324/haematol.2023.284238.